SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-367340
Filing Date
2015-11-05
Accepted
2015-11-05 08:33:41
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d64870d10q.htm 10-Q 798133
2 EX-31.1 d64870dex311.htm EX-31.1 8701
3 EX-31.2 d64870dex312.htm EX-31.2 8696
4 EX-32.1 d64870dex321.htm EX-32.1 5509
  Complete submission text file 0001193125-15-367340.txt   4421916

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgnx-20150930.xml EX-101.INS 708297
6 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20150930.xsd EX-101.SCH 45021
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgnx-20150930_cal.xml EX-101.CAL 66788
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgnx-20150930_def.xml EX-101.DEF 233073
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20150930_lab.xml EX-101.LAB 416501
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20150930_pre.xml EX-101.PRE 316153
Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37553 | Film No.: 151198958
SIC: 2836 Biological Products, (No Diagnostic Substances)